---
document_datetime: 2023-11-30 16:10:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/inaqovi-epar-all-authorised-presentations_en.pdf
document_name: inaqovi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6387672
conversion_datetime: 2025-12-31 05:17:15.56302
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number        | (Invented) name   | Strength       | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|----------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/23/1756/001 | Inaqovi           | 35 mg / 100 mg | film-coated tablet    | Oral use                  | Blister (Alu/PVC)     | 5 tablets   |